Virtual Medicinal Product (VMP)
-
Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection vials
Name Details
Current Name
Aripiprazole 400mg powder and solvent for prolonged-release suspension for injection vials
|
Start Date
01-07-2024
|
End Date
|
Previous Name
Aripiprazole 400mg powder and solvent for suspension for injection vials
|
Start Date
12-12-2013
|
End Date
30-06-2024
|
|
Abbreviated Name
Aripiprazole 400mg inj vials
|
Start Date
12-12-2013
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05AX12
BNF |
Current BNF
04020200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04020200
|
Start Date
25-06-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
23661211000001102 |
12-12-2013 |
|
VMP Ingredients
VMP ingredients table
Aripiprazole |
Based on Ingredient Substance |
|
400 mg |
|
Name
Aripiprazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
400
Strength and UOM (Dmr)
Parent Products
-
VTM
Aripiprazole
-
VMP
(Current) Aripiprazole 400mg powder and solven...
Virtual Medicinal Product Pack (VMPP) Information
1 vial |
22041 |
Part VIIIA Category C |